Cargando…
Inflammatory changes in tumour vessels after systemic 5-hydroxytryptamine, bradykinin, kallikrein, or lysolecithin.
Autores principales: | Cater, D. B., Taylor, C. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1966
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008015/ https://www.ncbi.nlm.nih.gov/pubmed/4288477 |
Ejemplares similares
-
Effect of lysolecithin on the oxygen uptake of tumour cells, polymorphonuclear leucocytes, lymphocytes and macrophages in vitro.
por: Butterworth, A. E., et al.
Publicado: (1967) -
Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin
Receptor Antagonism
por: Riedl, Marc
Publicado: (2010) -
Vasomotor Effects of Acetylcholine, Bradykinin, Noradrenaline,
5-Hydroxytryptamine, Histamine and Angiotensin II on the Mouse Basilar
Artery
por: ISLAM, Md. Zahorul, et al.
Publicado: (2014) -
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
por: Hintze, Stefan, et al.
Publicado: (2023) -
Pharmacologic Targets and Prototype Therapeutics in the Kallikrein-Kinin System: Bradykinin Receptor Agonists or Antagonists
por: Sharma, J. N., et al.
Publicado: (2006)